ANP-010

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameANP-010
Drug Alias NameANP-010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor antagonistsDopamine receptors antagonistsAdrenergic receptors antagonists
TargetsAdrenergic receptorsSerotonin (5-HT) receptorDopamine receptors
Therapy Area/IndicationsSchizophreniaBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesANP Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesANP Therapeutics
Active IndicationsN/A
Inactive IndicationsSchizophreniaBipolar Disorder

Other Information

ATC CodeN/A
Related LinksN/A